June 15 2018 - Much good news for Bluebird Bio

June 15 2018 - Much good news for Bluebird Bio

Bluebird bio announces good news in both sickle cell disease and beta thalassemia
Insys testing epi nasal spray to compete with EpiPen
Teva discontinuing chronic cluster headache trial
ASCO and its messages on cancer drug value
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Our microbiome database currently has 73 conditions for which biome-based products are being developed, & more added regularly. Review products by company, conditions treated, stage of development. Free access w/a subscription to our premium newsletter.


Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

image: